The ANMF supports the the Therapeutic Goods Administration’s (TGA) decision to improve access to medical terminations, by amending the prescribing and dispensing restrictions on MS-2 Step (mifepristone and misoprostol).
Allowing highly-qualified NPs to prescribe MS-2 Step on the PBS, will go a long way in removing some of the barriers that exist for women, particularly in rural and remote areas.
This reform will enable NPs to work to their full scope of practice and the prescription of MS-2 Step by NPs will be subsidised on the Pharmaceutical Benefits Scheme (PBS).
Nurses and midwives provide care across all reproductive healthcare services and, as female dominated professions, often have direct experience of the enablers and barriers to universal access to sexual and reproductive health services for women.
Achieving priorities under the National Women’s Health Strategy is imperative for the health of all people living in Australia, the health of Australian communities, short-and long-term equity for women, and for helping professions to continue to provide care.
The ANMF, with over 322,000 members, is the industrial and professional voice for nurses, midwives and carers in Australia.
ANMF Statement authorised by Lori-Anne Sharp, ANMF A/Federal Secretary. 1/365 Queen St, Melbourne.
